Concurrent Chemoradiotherapy for Limited-disease Small Cell Lung Cancer in Elderly Patients Aged 75 Years or Older
Toshio Shimizu(Wakayama Medical University), Tomohide Tamura(St. Luke's International Hospital), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Ikuo Sekine(University of Tsukuba), Yuichiro Ohe(National Cancer Center), Yoshinori Ito(National Cancer Center Hospital East), Kazuhiko Yamada, Hiroshi Nokihara(Tokushima University Hospital), Hideo Kunitoh(Japanese Red Cross Medical Center), Noboru Yamamoto(Tokyo National Hospital)
Cited by 12
Related Papers
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
|New England Journal of Medicine|2009|8.2k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
E-CELL: software environment for whole-cell simulation.
|Bioinformatics|1999|765